Mallinckrodt PLC Rating Reiterated by Keefe, Bruyette & Woods (MNK)
Mallinckrodt PLC (NYSE:MNK)‘s stock had its “market perform” rating reiterated by equities researchers at Keefe, Bruyette & Woods in a research report issued on Friday. They currently have a $77.00 price objective on the stock, down from their previous price objective of $90.00. Keefe, Bruyette & Woods’ target price would indicate a potential upside of 10.90% from the stock’s previous close.
MNK has been the subject of a number of other recent research reports. Analysts at Bank of America raised their price target on shares of Mallinckrodt PLC to $97.00 in a research note on Tuesday, July 29th. Separately, analysts at Deutsche Bank initiated coverage on shares of Mallinckrodt PLC in a research note on Tuesday, July 22nd. They set a “buy” rating and a $96.00 price target on the stock. Finally, analysts at Jefferies Group raised their price target on shares of Mallinckrodt PLC from $85.00 to $95.00 in a research note on Monday, July 21st. They now have a “buy” rating on the stock. Five equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $85.78.
In other Mallinckrodt PLC news, major shareholder Paulson & Co Inc bought 275,000 shares of the stock in a transaction that occurred on Friday, August 1st. The shares were purchased at an average cost of $69.60 per share, for a total transaction of $19,140,000.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.
Mallinckrodt PLC (NYSE:MNK) opened at 69.43 on Friday. Mallinckrodt PLC has a 1-year low of $41.67 and a 1-year high of $83.20. The stock’s 50-day moving average is $75.05 and its 200-day moving average is $70.19. The company has a market cap of $4.066 billion and a P/E ratio of 64.11.
Mallinckrodt PLC (NYSE:MNK) last posted its quarterly earnings results on Thursday, August 7th. The company reported $1.20 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.87 by $0.33. The company had revenue of $653.10 million for the quarter, compared to the consensus estimate of $278.80 million. During the same quarter in the prior year, the company posted $0.49 earnings per share. The company’s quarterly revenue was up 14.6% on a year-over-year basis. Analysts expect that Mallinckrodt PLC will post $3.71 EPS for the current fiscal year.
Mallinckrodt public limited company (NYSE:MNK) is a global specialty pharmaceuticals company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.